Trying Whole Virus Next?
Iomai's Patch For Flu Vaccine Fails To Beat Injected Version
By Randall Osborne
Tuesday, May 29, 2007
Iomai Corp.'s Phase I flop with its influenza-vaccine patch knocked shares down 40 percent, and sent researchers back to the drawing board - armed, at least, with data that their adjuvant to the vaccine, called LT, helped response. (BioWorld Today)
Outside of the US
Part of Thomson Reuters
Note: our contact information has changed
In the U.S. and Canada: +1-800-336-4474
Outside the U.S.: +44-203-684-1796
Hours: Monday - Friday, 8:00am - 6:00 pm EST
© 2017 Thomson Reuters. Reproduction, reposting content is strictly prohibited.